Flex Pharma Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

  • Investments
  • 2

Flex Pharma General Information

Description

Salarius Pharmaceuticals Inc formerly known as Flex Pharma Inc is a US-based biotechnology company which is engaged in the developing proprietary treatments for muscle cramps and spasms associated with severe neurological conditions and exercise-associated muscle cramps. The lead drug product candidate is FLX-787 which is a single molecule, chemically synthesized, TRP ion channel activator and HOTSHOT, which is developed to prevent and treat exercise-associated muscle cramps. It operates through two segments - Consumer Operations and Drug Development. The Consumer Operations segment includes the development of HOTSHOT whereas the Drug Development segment includes the development of proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 800 Boylston Street
  • 24th Floor
  • Boston, MA 02199
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Decoy Therapeutics
Corporate Office
  • 800 Boylston Street
  • 24th Floor
  • Boston, MA 02199
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Flex Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Flex Pharma‘s full profile, request access.

Request a free trial

Flex Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Salarius Pharmaceuticals Inc formerly known as Flex Pharma Inc is a US-based biotechnology company which is engaged in t
Drug Discovery
Boston, MA

Toronto, Canada
 

La Jolla, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Flex Pharma Competitors (18)

One of Flex Pharma’s 18 competitors is ProMIS Neurosciences, a Corporation company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ProMIS Neurosciences Corporation Toronto, Canada
CalciMedica Formerly VC-backed La Jolla, CA
Minerva Neurosciences Formerly VC-backed Burlington, MA
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
Orgenesis Corporation Germantown, MD
You’re viewing 5 of 18 competitors. Get the full list »

Flex Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Flex Pharma‘s full profile, request access.

Request a free trial

Flex Pharma Acquisitions (2)

Flex Pharma’s most recent deal was a Reverse Merger with Decoy Therapeutics. The deal was made on 22-Jul-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Decoy Therapeutics 22-Jul-2019 Reverse Merger Drug Discovery
Decoy Therapeutics 04-Jan-2019 Merger/Acquisition Drug Discovery
To view Flex Pharma’s complete acquisitions history, request access »

Flex Pharma Exits (2)

Flex Pharma’s most recent exit was on 22-Jul-2019 from Decoy Therapeutics. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Decoy Therapeutics 22-Jul-2019 Completed
Decoy Therapeutics 04-Jan-2019 Merger/Acquisition Completed
To view Flex Pharma’s complete exits history, request access »

Flex Pharma FAQs

  • When was Flex Pharma founded?

    Flex Pharma was founded in 2014.

  • Where is Flex Pharma headquartered?

    Flex Pharma is headquartered in Boston, MA.

  • What industry is Flex Pharma in?

    Flex Pharma’s primary industry is Drug Discovery.

  • Is Flex Pharma a private or public company?

    Flex Pharma is a Private company.

  • What is the current valuation of Flex Pharma?

    The current valuation of Flex Pharma is .

  • What is Flex Pharma’s current revenue?

    The current revenue for Flex Pharma is .

  • How much funding has Flex Pharma raised over time?

    Flex Pharma has raised $121M.

  • Who are Flex Pharma’s investors?

    Alexandria Venture Investments, Bessemer Venture Partners, Bindley Capital Partners, CD-Venture, and City Hill Ventures are 5 of 11 investors who have invested in Flex Pharma.

  • Who are Flex Pharma’s competitors?

    ProMIS Neurosciences, CalciMedica, Minerva Neurosciences, ACADIA Pharmaceuticals, and Orgenesis are some of the 18 competitors of Flex Pharma.

  • When was Flex Pharma acquired?

    Flex Pharma was acquired on 19-Jul-2019.

  • Who acquired Flex Pharma?

    Flex Pharma was acquired by Decoy Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process